Mechanical limitation during CO2 rebreathing in young patients with cystic fibrosis

被引:2
|
作者
Fauroux, Brigitte [1 ]
Nicot, Frederic
Boelle, Pierre-Yves
Boule, Michele
Clement, Annick
Lofaso, Frederic
Bonora, Monique
机构
[1] Assistance Publ Hop Paris, Armand Trousseau Hosp, Pediat Pulm Dept, Paris, France
[2] Assistance Publ Hop Paris, Armand Trousseau Hosp, INSERM, U 719, Paris, France
[3] Assistance Publ Hop Paris, Hop St Antoine, Dept Biostat, INSERM U 444, Paris, France
[4] Assistance Publ Hop Paris, Raymond Poincare Hosp, Dept Physiol, Garches, France
关键词
carbon dioxide rebreathing; cystic fibrosis; children; hypercapnia; work of breathing; lung compliance;
D O I
10.1016/j.resp.2005.11.002
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The aim of the study was to determine whether a decrease in the ventilatory response to carbon dioxide (CO2) in children with cystic fibrosis (CF) is related to a mechanical limitation of the respiratory muscle capacity. The ventilatory response during CO2 rebreathing was performed in 15 patients (mean forced expiratory volume in 1 s (FEV1): 37 +/- 21 % predicted, mean arterial CO2: 41 +/- 5 mmHg). The slope of the minute ventilation normalised for weight per mmHg CO2 increment correlated negatively with respiratory muscle output, assessed by the oesophageal (p = 0.002), the diaphragmatic pressure time product (P = 0.01), and the tension time index (p = 0.005). In addition, this slope was correlated with dynamic lung compliance (p < 0.0001) and FEV1 (p = 0.03) but not with airway resistance and maximal transdiaphragmatic pressure. Therefore, an excessive load imposed on the respiratory muscles explains the blunting of the ventilatory response to CO2 in young patients with CF. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:217 / 225
页数:9
相关论文
共 50 条
  • [21] THORACOABDOMINAL MOTION DURING CO2 REBREATHING WITH INSPIRATORY FLOW RESISTANCE
    LOPATA, M
    EVANICH, MJ
    LOURENCO, RV
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1978, 117 (04): : 365 - 365
  • [22] VENTILATORY RESPONSE OF THE SLEEPING NEWBORN TO CO2 DURING NORMOXIC REBREATHING
    COHEN, G
    XU, C
    HENDERSONSMART, D
    JOURNAL OF APPLIED PHYSIOLOGY, 1991, 71 (01) : 168 - 174
  • [23] EFFECTS OF POSITION ON RESPIRATORY MUSCLE FUNCTION DURING CO2 REBREATHING
    LOPATA, M
    OCONNOR, TD
    ONAL, E
    RESPIRATION, 1985, 47 (02) : 98 - 106
  • [24] CONFIGURATION OF CHEST WALL AND OCCLUSION PRESSURE DURING CO2 REBREATHING
    WHITELAW, WA
    DERENNE, JP
    ALMIRALL, J
    GRASSINO, AG
    FEDERATION PROCEEDINGS, 1977, 36 (03) : 445 - 445
  • [25] REBREATHING AND ENDTIDAL CO2 DURING SPONTANEOUS BREATHING WITH THE BAIN CIRCUIT
    SPOEREL, WE
    CANADIAN ANAESTHETISTS SOCIETY JOURNAL, 1983, 30 (02) : 148 - 154
  • [26] Mixed venous CO2 and ventilation during exercise and CO2-rebreathing in humans
    Satoh, T
    Okada, Y
    Hara, Y
    Sakamaki, F
    Kyotani, S
    Tomita, T
    POST-GENOMIC PERSPECTIVES IN MODELING AND CONTROL OF BREATHING, 2004, 551 : 269 - 274
  • [27] EVALUATION OF A CO2 PARTIAL REBREATHING FUNCTIONAL RESIDUAL CAPACITY MEASUREMENT METHOD FOR USE DURING MECHANICAL VENTILATION
    Brewer, Lara
    Orr, Joseph
    Fulcher, Earl
    Markewitz, Boaz
    JOURNAL OF CLINICAL MONITORING AND COMPUTING, 2011, 25 (06) : 397 - 404
  • [28] Evaluation of a CO2 partial rebreathing functional residual capacity measurement method for use during mechanical ventilation
    Lara Brewer
    Joseph Orr
    Earl Fulcher
    Boaz Markewitz
    Journal of Clinical Monitoring and Computing, 2011, 25 : 397 - 404
  • [29] CARDIAC-OUTPUT WITH CO2 REBREATHING METHOD IN CAPD PATIENTS
    BERTOLI, S
    SCORZA, D
    GENDERINI, A
    BARONE, MT
    MILANI, S
    SERGI, M
    RIZZI, M
    BOSISIO, E
    DIBELGIOJOSO, GB
    ADVANCES IN PERITONEAL DIALYSIS, VOL 5, 1989: SELECTED PAPERS FROM THE NINTH ANNUAL CONFERENCE ON PERITONEAL DIALYSIS, 1989, 5 : 42 - 45
  • [30] EFFICACY OF 4 RESPIRATORY ANALEPTICS ON HEALTHY YOUNG MEN IN A CO2 REBREATHING EXPERIMENT
    WIESSMANN, KJ
    STEINIJANS, VW
    BROSSMANN, D
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1979, 29-1 (02): : 329 - 333